iCoreConnect Inc. Announces Appointment of Two Leading Industry Executives to Its Board of Directors
Ocoee, FL, Jan. 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- iCoreConnect, Inc., (OTCQB: ICCT), a cloud based Software-as-a-Service (SaaS) company with an enterprise and healthcare workflow platform, announced the appointment of Kevin McDermott, SAP, and Harry Travis, The Travis Group, to the company’s Board of Directors.
Kevin McDermott has been with SAP for 19 years and presently is Head of North American Channel Sales for SAP. Throughout Kevin's highly successful career, he has earned the highest corporate accolades and achievements. He and his teams at both Xerox and SAP have consistently overachieved.
Harry Travis is President of The Travis Group. Prior to forming his company, Harry was Senior Vice President, Member Services Operations at CVS Caremark. Prior to joining CVS Caremark in 2020, he was the President and CEO of digital health startup etectRx, Inc. which developed an innovative digital pill system that incorporates a tiny ingestible sensor into a capsule. He is a nationally known speaker on the topic of the disruptive impact of digital technologies on the practice and business of pharmacy. He holds a BS in Pharmacy from the University of Pittsburgh, School of Pharmacy and an MBA from The Darden School at the University of Virginia.
Robert McDermott, President and CEO of iCoreConnect, states, “With the recent announcement of our business combination agreement with FG Merger Corp. and the anticipated move to the Nasdaq, we are looking to strengthen our board to enhance shareholder value and expand our reach into enterprise customers.”
Kevin remarks, “I am very excited to join the Board of Directors of iCoreConnect and look forward to working with Robert and the other board members.”
“Harry has held senior leadership positions with Baxter Healthcare, Cardinal Health, Accredo/Medco, Aetna and CVS,” elaborates Robert McDermott. “His track record includes successful P&L management of high growth specialty pharmaceutical distribution companies with over two billion in annual revenue. The expertise he brings to the board is tremendous.”
“iCoreConnect’s applications and services are needed more than ever as all healthcare providers search for improvements in productivity and quality. I am excited to bring my expertise to the iCoreConnect board,” states Harry Travis.
About iCoreConnect, Inc. (OTCQB: ICCT)
iCoreConnect, Inc. is a market leading, cloud-based software and technology company focused on increasing workflow productivity and practice profitability through its enterprise and healthcare workflow platform of applications and services. iCoreConnect is most notably known for its innovation in solving healthcare business problems. The company’s philosophy places a high value on customer feedback, allowing iCoreConnect to respond to the market’s needs. iCoreConnect touts a platform of 15 SaaS enterprise solutions and more than 90 agreements with state or regional healthcare associations across the U.S.
FORWARD-LOOKING STATEMENTS:
Some of the statements in this news release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. The Company has attempted to identify forward-looking statements by terminology including "believe," "could," "expect," "may," "positioned," "project," "projected," "should," "will," "would," or similar expressions are intended to identify forward-looking statements that represent the Company's current judgment about possible future events. Forward-looking statements in this news release include, but are not limited to, statements regarding the Company’s ability to complete its business combination with FG Merger Corp. and to become listed on Nasdaq. The Company believes these judgments are reasonable, but these statements are not guarantees of any events or financial results, and actual results may differ materially due to a variety of important factors. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. “Risk Factors” in the Company’s most recently filed Form 10-K filed with the Securities and Exchange Commission (“SEC”) and updated from time to time in the Company’s Form 10-Q filings and in the Company’s other public filings with the SEC. Any forward-looking statements contained in this news release speak only as of its date. The Company undertakes no obligation to update any forward-looking statements contained in this news release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.
Contact:
Brian Loper
602-785-4120
brian@clearthink.capital
Released January 30, 2023